Clarity Pharmaceuticals Ltd.ASX: CU6

First patient treated in therapeutic prostate cancer trial

Oct 7, 2022 at 3:07 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment